妊娠合并心脏疾病预防及管理研究进展

Advances in the prevention and management of heart disease in pregnancy

随着我国二胎政策开放,孕产妇数量增多。怀孕对心血管系统产生巨大的影响,妊娠合并心脏病增加孕产妇心力衰竭及死亡风险,同时也增加胎儿宫内发育迟缓、早产等并发症风险。妊娠合并心脏病在我国孕产妇非直接产科死因中位居第一,降低孕产妇死亡率是世界卫生组织的全球目标。因此,加强妊娠合并心脏病患者的预防及管理至关重要,而妊娠合并心脏病患者的临床决策及管理尚存在争议。本文结合近年国内外发表的相关妊娠合并心脏疾病文献,综述相关的诊断和治疗方法,旨在为妊娠合并心脏病患者的全程预防保健和管理策略提供临床参考。

With the opening of the two child policy in China,the number of pregnant women has increased.Pregnancy has a huge impact on the cardiovascular system,and heart disease during pregnancy increases the risk of maternal heart failure and death,intrauterine growth retardation,and the risk of complications such as premature birth.Pregnancy with heart disease ranks first among indirect obstetric deaths in China.Reducing maternal mortality is a global goal of the World Health Organization.Thus,to strengthen the prevention and management of patients with critical heart disease during pregnancy is important.However,clinical decision-making and management of pregnant women with heart disease is still controversial.This article combines relevant literature of pregnancy and heart disease published in recent years and reviews of relevant diagnostic and therapeutic methods,to provide clinical reference for pregnant women with heart disease preventive care and management of the whole strategy.